298 related articles for article (PubMed ID: 22589524)
1. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.
Schwope DM; Bosker WM; Ramaekers JG; Gorelick DA; Huestis MA
J Anal Toxicol; 2012 Jul; 36(6):405-12. PubMed ID: 22589524
[TBL] [Abstract][Full Text] [Related]
2. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
3. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Schwope DM; Karschner EL; Gorelick DA; Huestis MA
Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
[TBL] [Abstract][Full Text] [Related]
4. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
5. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
[TBL] [Abstract][Full Text] [Related]
7. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
8. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects.
Brands B; Mann RE; Wickens CM; Sproule B; Stoduto G; Sayer GS; Burston J; Pan JF; Matheson J; Stefan C; George TP; Huestis MA; Rehm J; Le Foll B
Drug Alcohol Depend; 2019 Dec; 205():107641. PubMed ID: 31678833
[TBL] [Abstract][Full Text] [Related]
9. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
[TBL] [Abstract][Full Text] [Related]
11. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):690-701. PubMed ID: 26257143
[TBL] [Abstract][Full Text] [Related]
12. Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers.
Desrosiers NA; Ramaekers JG; Chauchard E; Gorelick DA; Huestis MA
J Anal Toxicol; 2015 May; 39(4):251-61. PubMed ID: 25745105
[TBL] [Abstract][Full Text] [Related]
13. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
[TBL] [Abstract][Full Text] [Related]
14. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
16. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
18. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
20. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]